0

Global Anemia Therapeutics Market 2017-2021

  • Published: Oct 2017
  • Pages: 84
  • SKU: IRTNTR14378
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This market research study identifies AMAG Pharmaceuticals, Daiichi Sankyo, Galenica, and Pharmacosmos as the leading players in the global anemia therapeutics market. A comprehensive analysis of this market is also presented by disease type (iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia, and others) and by geography (the Americas, APAC, and EMEA).

Overview of the global anemia therapeutics market

Research analysis on the global anemia therapeutics market identifies that the new drug approvals for the treatment of various types of anemia or rare blood disorders will be one of the major factors that will have a positive impact on the growth of the market. The use of endari (L-glutamine oral powder) for the treatment of sickle cell disease in patients, aged five years and above, was approved by the US food and drug administration (FDA) in July 2017. Sickle cell disease is a rare blood disorder, which requires lifelong treatment. In addition, the government is supporting the manufacturer of endari, Emmaus, to facilitate research and developmental activities in the rare disease area. The granting of the orphan drug designation enabled them to earn financial incentives, market exclusivity, and shorter review periods. Similarly, the erythropoiesis-stimulating agent (ESA) called peginesatide for the treatment of anemia in CKD-affected patients undergoing dialysis or kidney anemia was also approved by the US FDA in March 2012. Technavio’s market research analysts predict that this market will grow at a CAGR of close to 9% by 2021.

The low level of oxygen in the body can cause a condition called hypoxia. As a result, researchers are focusing on the development of hypoxia-inducible factor (HIF) stabilizers for the treatment of anemia associated with chronic kidney disease (CKD). For instance, FibroGen's FG-2216 AND FG-4592 are anemia therapeutics for anemia treatment that leads to increased stability of HIF-2 alpha in the kidney by inhibiting the HIF prolyl hydroxylase. According to this research analysis, the development of HIF stabilizers will be one of the key trends that will gain traction in the anemia therapeutics market during the projected period.

Competitive landscape and key vendors

The anemia therapeutics market is characterized by the presence of many large and small vendors. These vendors are increasingly competing against each other based on factors such as aggressive pricing, novel therapeutics, and advancements in technology. Vendors in the anemia drugs market are also focusing on expanding their geographical reach by increasing their investments in the research and developmental activities.

Key vendors in this market are -

  • AMAG Pharmaceuticals
  • Daiichi Sankyo
  • Galenica
  • Pharmacosmos

Other prominent vendors in the market include Acceleron Pharma, Bayer, GlycoMimetics, GlaxoSmithKline, Novartis, Pieris Pharmaceuticals, and Sanofi.

Segmentation by disease type and analysis of the anemia therapeutics market

  • Iron deficiency anemia
  • Sickle cell anemia
  • Pernicious anemia
  • Hemolytic anemia

The iron deficiency anemia market segment accounted for the major shares of the anemia drugs market during 2016. The prevalence of iron deficiency anemia is increasing in the developing as well as developed countries. Also, around 5% women and 2% men in America are affected by the iron deficiency anemia as per the National Institutes of Health (NIH). The low bioavailability of iron in the diet in developing countries and poor iron absorption and blood loss in developed countries are the main causes of iron deficiency anemia. This drives the need for oral iron therapeutics as the first-line therapy.

Segmentation by geography and analysis of the anemia therapeutics market

  • Americas
  • APAC
  • EMEA

It has been observed that the incidence of various types of anemia is increasing in the Americas. This is compelling vendors such as Daiichi Sankyo to focus on the development of intravenous anemia therapeutics. The increasing demand for a ferric carboxymaltose iron solution for iron deficiency anaemia will boost the adoption of CKD and anemia therapeutics in the Americas during the next four years. The Americas will be the major contributor to the anemia therapeutics market throughout the next few years.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2021?
  • What are the key factors driving the global anemia therapeutics market?
  • What are the key market trends impacting the growth of the global anemia therapeutics market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global anemia therapeutics market?
  • What are the market opportunities and threats faced by the vendors in the global anemia therapeutics market?
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
  • What are the key outcomes of the five forces analysis of the global anemia therapeutics market?

Technavio also offers customization on reports based on specific client requirement

 

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Anemia: A brief overview

  • Anemia
  • Symptoms
  • Classification of anemia
  • Causes of anemia
  • Treatment

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Pipeline Landscape

PART 08: Market segmentation by disease type

  • Iron deficiency anemia
  • Sickle cell anemia
  • Pernicious anemia
  • Hemolytic anemia
  • Others

PART 09: Geographical segmentation

  • Anemia therapeutics market in Americas
  • Anemia therapeutics market in EMEA
  • Anemia therapeutics market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Market challenges

PART 12: Market trends

  • Growing focus on HIF stabilizers
  • Growing focus on emerging economies
  • Increasing strategies of vendors to expand reach of anemia therapeutics

PART 13: Vendor landscape

  • Competitive scenario

PART 14: Key vendor analysis

  • AMAG Pharmaceuticals
  • Daiichi Sankyo
  • Galenica
  • Pharmacosmos
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>